Skip to contentG
Guided Therapeutics Inc
G
GTHPGuided Therapeutics Inc Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$13.00K$13.00Kderived−96.2% vs Q4 2013 Net Income-$3.20M-$3.20MderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$5,000N/M Operating Incomederived-$2,148,000N/M Margins · derivedGross margin38.5%+86.0 pt vs Q4 2013
Operating margin-16523.1%−16131.8 pt vs Q4 2013
Net margin-24592.3%−23951.1 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 25, 2015 · 84 d after period end